<div id="readability-page-1"><div> <div> Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Kennedy-Wilson Holdings, Inc. (NYSE: KW)'s sale to consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy-Wilson, and certain other senior executives of Kennedy-Wilson, together with Fairfax Financial Holdings Limited, for $10.90 per share in cash. If you are a Kennedy-Wilson shareholder, click here to learn more about your rights and options. Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options. Affinity Bancshares, Inc. (NASDAQ: AFBI)'s sale to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash, subject to adjustment based on Affinity's adjusted stockholders' equity at closing. If you are an Affinity shareholder, click here to learn more about your legal rights and options. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4"/></div> </div></div>

BRNS

AFBI

Halper Sadeh LLC is investigating Kennedy-Wilson Holdings, Barinthus Biotherapeutics, and Affinity Bancshares for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders. Shareholders are encouraged to contact the firm for legal rights and options regarding the proposed transactions, which include a sale of Kennedy-Wilson for $10.90 per share, a merger involving Barinthus, and a sale of Affinity for $23.00 per share.

02:54 ETAre KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?